• 2年经验
  • 招1人
  • 英语熟练
  • 11-09 发布

职位描述

职位描述: Job Purpose:Be responsible for drug policy analysis on health, handle central health affairs and drive health related projects 1.Monitor and analyze Essential drug policy. Evaluate NEDL policy impact to NVS business and ensure NVS products’ access to NDEL when access window available.2.Closely collect information on national negotiation of drug and handle the involved NVS products’ negotiation during NHFPC negotiations.3.Work closely with BUs, KA, commercial, finance and other relevant departments/functions to gain cross-functional support on central health affairs.4.Maintain effective and regular communications with central health authorities and relevant associations5.Design and execute drug policy focused projects to build and main-tain partnership relationship with NHDRC6.Monitor health policies especially some cross-ministry policies to seek business opportunity or evaluate potential risk to NVSKey Performance Indicators:Minimize price cut during national negotiation and maximize access opportunity when NDEL updateIdeal Background:Education: Bachelor degree or above of related majors (PharmaceuticalAdministration or Healthcare policy related majors is preferred)Languages: Excellent English skillsExperience: 2+years’Working experience in Central Health or other relevant experience within pharmaceutical industry (working or intern experience in NHFPC(卫计委) is preferred) 职能类别: 政府事务管理

联系方式

建国门外大街1号国贸大厦2座

公司信息

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药,涵盖的疾病领域包括:心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。 “诺华”中文取意“承诺中华”,即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年,总部设在北京,隶属于瑞士诺华公司。 诺华公司致力于为患者及社会提供创新医药保健解决方案,以满足其日益变化的健康需求。2011年,集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元(去除减值及摊销后为92亿美元)。诺华集团总部位于瑞士巴塞尔,业务遍及全球140多个国家和地区,拥有124,000位全职员工。诺华集团立足在中国的长期发展,重要战略投资包括位于上海的综合性生物医学研发中心,以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息,敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。

猎才二维码